Universal-Beteiligungs- und Servicegesellschaft
NRIX icon

Universal-Beteiligungs- und Servicegesellschaft’s Nurix Therapeutics NRIX Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,830
Closed -$224K – 2069
2025
Q1 		$224K Buy
+18,830
New +$315K ﹤0.01% 1855

Other funds holding NRIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's NRIX Position: Q2 2025 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Nurix Therapeutics (NRIX) in Q2 2025, closing a stake of 18,830 shares — an estimated $224K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in NRIX in Q1 2025 and held it in 1 quarter. The position peaked at $224K in Q1 2025. 163 funds tracked by Wall St. Rank hold NRIX as of Q2 2025.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining Nurix Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 18,830 Nurix Therapeutics shares in Q2 2025, an estimated $224K.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Nurix Therapeutics in Q1 2025 and held it in 1 quarter.
  • Universal-Beteiligungs- und Servicegesellschaft's Nurix Therapeutics position peaked at $224K in Q1 2025.
  • 163 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2025.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2025, filed 11 Aug 2025.